Therma Bright Inc.

Therma Bright Inc. develops proprietary diagnostic and medical device technologies focused on health management solutions. Its product offerings include the Venowave circulation booster for blood clot prevention, the Digital Cough Test (DCT) for detecting respiratory diseases using AI, and an inhaled statin therapy for COVID-19 pneumonia. The company also collaborates on the PREVA™ clot retriever, designed to enhance ischemic stroke treatment by improving clot removal during thrombectomy procedures. Therma Bright operates primarily in the healthcare sector, targeting patients and healthcare providers.